The latest Covid-19 vaccines from Pfizer and Moderna

The latest Covid-19 vaccines from Pfizer and Moderna tend to be exceptionally effective at avoiding severe illness.

4,000 active cases among inmates and 1,430 more among workers in California

More than 4,000 active cases among inmates and 1,430 more among workers in California.

The CDC has updated its guidelines on the spread of COVID-19

The CDC has updated its guidelines on the spread of COVID-19.

Public health authorities and drug manufacturers need to be open regarding the side effects of coronavirus vaccine

Public health authorities and drug manufacturers need to be open regarding the side effects of coronavirus vaccines, doctors say.

Patients with Type O or B blood spent less time in ICU than those with Type A or AB

Patients with Type O or B blood spent less time in ICU than those with Type A or AB.

COVID-19 assaults our immune system

In an isolated laboratory at the Icahn School of Medicine in Mount Sinai, East Harlem, virologist Benjamin never has been able to decipher how the virus that causes COVID-19 assaults our immune system, wreaking havoc like no other virus he has ever examined.

It has been more than 300 days since Chinese authorities first told the World Health Organisation

It has been more than 300 days since Chinese authorities first told the World Health Organisation that Wuhan residents were sick with a mysterious virus.

Some Covid-19 patients experience a long-lasting skin issues following the infection

Some Covid-19 patients experience a long-lasting skin issues following the infection, researchers from Massachusetts General Hospital are finding, including rashes, hives, and “Covid toes.”

The spread of the Covid-19 among members in a family group

The spread of the Covid-19 among members in a family group after one individual is infected is “common” and occurs quickly after illness onset, relating to new research through the US Centers for Disease Control and Prevention.

Regeneron Pharmaceuticals has paused critically ill COVID-19 patients’ enrollment

Regeneron Pharmaceuticals has paused critically ill COVID-19 patients’ enrollment with its trial studying the antibody cocktail treatment, which was fond of President Trump earlier this month.